Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/20/2025

Appropriate Use of Azithromycin in Respiratory Infections

Introduction to Azithromycin Use

  • The American College of Physicians recommends against routine antibiotic treatment for acute uncomplicated bronchitis, even though macrolides, including azithromycin, are frequently prescribed 1
  • A systematic review found limited evidence supporting antibiotics for acute bronchitis, with a trend toward increased adverse events in antibiotic-treated patients 1
  • Antibiotic therapy does not decrease symptom duration, lost work time, or prevent complications in nonspecific URIs 4

Diagnosis and Treatment Criteria

  • Over 80-90% of acute upper respiratory infections are caused by viruses, not bacteria 2, 3
  • Most uncomplicated URIs resolve spontaneously within 1-2 weeks without antibiotic therapy 2, 4
  • Purulent nasal discharge or sputum does not indicate bacterial infection and does not justify antibiotic use 2, 4
  • Azithromycin should be reserved for confirmed bacterial infections, such as Group A Streptococcal Pharyngitis, Acute Bacterial Sinusitis, and Acute Bacterial Exacerbations of COPD 4, 5
  • Clinical signs alone cannot reliably diagnose streptococcal pharyngitis, and a rapid antigen test or throat culture is necessary 4

Contraindications and Safety Considerations

  • Inappropriate macrolide use contributes to rising antimicrobial resistance 6, 7
  • Macrolide-resistant respiratory pathogens increased 2.7-fold in patients receiving azithromycin prophylaxis 7
  • When azithromycin is prescribed, clinicians should perform baseline ECG to assess QTc interval, check baseline liver function tests, and review medication list for QT-prolonging drugs 6